CATALYST PHARMA (CN2.SG)
CATALYST PHARMA (CN2.SG) operates in Diversified Metals & Mining.
CATALYST PHARMA (CN2.SG) (CN2) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.110x
Based on the latest financial reports, CATALYST PHARMA (CN2.SG) (CN2) has a cash flow conversion efficiency ratio of 0.110x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€72.87 Million) by net assets (€660.94 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CATALYST PHARMA (CN2.SG) - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how CATALYST PHARMA (CN2.SG)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CATALYST PHARMA (CN2.SG) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CATALYST PHARMA (CN2.SG) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MARINE HARVEST
BE:PND
|
0.098x |
|
MOBISTAR - Dusseldorf Stock Exchang
DU:MOS
|
0.086x |
|
Ethernity Networks Ltd
PINK:ENETF
|
-0.542x |
|
ScreenPro Security Inc
PINK:SCRSF
|
-0.188x |
|
ATHENE HOLDING PRF.SER.C
F:ATR0
|
N/A |
|
Qrons Inc
OTCQB:QRON
|
0.006x |
|
Madoro Metals Corp
PINK:MSTXF
|
-0.062x |
|
Indel B SpA
STU:2I6
|
N/A |
Annual Cash Flow Conversion Efficiency for CATALYST PHARMA (CN2.SG) (2016–2023)
The table below shows the annual cash flow conversion efficiency of CATALYST PHARMA (CN2.SG) from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €387.88 Million | €143.60 Million | 0.370x | -4.16% |
| 2022-12-31 | €300.42 Million | €116.05 Million | 0.386x | +32.34% |
| 2021-12-31 | €206.83 Million | €60.37 Million | 0.292x | +9.93% |
| 2020-12-31 | €169.60 Million | €45.03 Million | 0.266x | -32.77% |
| 2019-12-31 | €87.63 Million | €34.61 Million | 0.395x | +178.03% |
| 2018-12-31 | €50.78 Million | €-25.70 Million | -0.506x | -198.20% |
| 2017-12-31 | €80.96 Million | €-13.74 Million | -0.170x | +62.86% |
| 2016-12-31 | €39.31 Million | €-17.96 Million | -0.457x | -- |